Published in Psychopharmacol Bull on January 01, 1992
Lorazepam-induced Short-term Remission of Symptoms in a Case of Paranoid Schizophrenia. Indian J Psychol Med (2011) 0.75
Treatment of the special patient with schizophrenia. Dialogues Clin Neurosci (2001) 0.75
Concept and Management of Treatment Resistant Schizophrenia (TRS). Indian J Psychiatry (2004) 0.75
[Pharmacotherapy for schizophrenia]. Nervenarzt (2006) 0.75
Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann (1979) 7.45
Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med (2000) 6.62
Cognitive effects of corticosteroids. Am J Psychiatry (1990) 2.85
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry (1998) 2.77
Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry (1998) 2.69
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol (1994) 2.03
Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol (1996) 1.96
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry (1997) 1.86
Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet (1996) 1.76
Development of major depression after treatment for smoking cessation. Am J Psychiatry (2000) 1.72
Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population. Am J Med Genet (1996) 1.65
Nicotine, negative affect, and depression. J Consult Clin Psychol (1993) 1.64
Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet (1999) 1.54
Prevention of depression with primary care patients: a randomized controlled trial. Am J Community Psychol (1995) 1.46
A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A (1996) 1.46
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Behavioral genetics. West J Med (1996) 1.39
Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry (2011) 1.36
Measuring physician behavior. Med Care (1986) 1.29
Effect of Proposition 187 on mental health service use in California: a case study. Health Aff (Millwood) (1996) 1.29
Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol Psychiatry (2003) 1.20
Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun (2012) 1.18
Treatment of depression with antiglucocorticoid drugs. Psychosom Med (1999) 1.15
Assortative mating in the affective disorders: a systematic review and meta-analysis. Compr Psychiatry (2001) 1.10
Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry (1999) 1.08
Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacol Bull (1996) 1.08
Lithium-induced thyrotoxicosis. Am J Psychiatry (1979) 1.06
Effect of lithium carbonate on memory processes of bipolar affectively ill patients. Psychopharmacology (Berl) (1979) 1.05
An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees. Am J Med Genet (1996) 1.05
Behavioral disturbances associated with endocrine disorders. Annu Rev Med (1986) 1.02
Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry (2001) 1.01
Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry (1997) 1.00
Self injurious behaviour in Tourette syndrome: correlates with impulsivity and impulse control. J Neurol Neurosurg Psychiatry (2004) 0.98
Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals. Arch Gen Psychiatry (2000) 0.98
Attitudes towards bipolar disorder and predictive genetic testing among patients and providers. J Med Genet (1996) 0.98
Short vs long hospitalization. A prospective controlled study. I. The preliminary results of a one-year follow-up schizophrenics. Arch Gen Psychiatry (1974) 0.95
Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry (1998) 0.94
Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol Psychiatry (1999) 0.93
Short versus long hospitalization: a prospective controlled study. V. One-year follow-up results for nonschizophrenie patients. Am J Psychiatry (1976) 0.91
Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci (1997) 0.91
Measuring adequacy of physician performance. A preliminary comparison of four methods in ambulatory care of chronic obstructive pulmonary disease. Med Care (1984) 0.90
The "atypical" clinical picture of adolescent mania. Am J Psychiatry (1982) 0.89
Clinical implications of state-dependent learning. Am J Psychiatry (1979) 0.88
Cortisol levels predict cognitive impairment induced by electroconvulsive therapy. Biol Psychiatry (2001) 0.87
Short vs long hospitalization: a prospective controlled study. VII. Two-year follow-up results for nonschizophrenics. Arch Gen Psychiatry (1977) 0.87
Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. Am J Med Genet (2001) 0.86
Clozapine eligibility among state hospital patients. Schizophr Bull (1996) 0.86
Withdrawal from heroin in three or six weeks. Comparison of methadyl acetate and methadone. Arch Gen Psychiatry (1982) 0.86
Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population. Proc Natl Acad Sci U S A (2001) 0.85
Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. Clin Pharmacol Ther (2007) 0.84
ACTH levels after the dexamethasone suppression test in depression. N Engl J Med (1982) 0.84
Short versus long hospitalization: a prospective controlled study. II. Results for schizophrenic inpatients. Am J Psychiatry (1975) 0.83
Short vs long hospitalization. A controlled study: III. Inpatient results for nonschizophrenics. Arch Gen Psychiatry (1976) 0.83
Vasopressin in affective illness. Lancet (1978) 0.82
Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients. World J Biol Psychiatry (2001) 0.82
Short versus long hospitalization: a propspective controlled study. IV. One-year follow-up results for schizophrenie patients. Am J Psychiatry (1976) 0.82
Heterogeneity of amphetamine response in depressed patients. Am J Psychiatry (1981) 0.81
Short vs long hospitalization: a prospective controlled study. VI Two-year follow-up results for schizophrenics. Arch Gen Psychiatry (1977) 0.81
Effects of stringent criteria on eligibility for clozapine among public mental health clients. Psychiatr Serv (1995) 0.81
d-Amphetamine: effects on memory in a depressed population. Biol Psychiatry (1979) 0.80
Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry (1993) 0.80
The Program Environment Scale: assessing client perceptions of community-based programs for the severely mentally ill. Am J Community Psychol (1998) 0.80
Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann N Y Acad Sci (1995) 0.80
Women on LAAM maintenance: initial experiences. J Psychedelic Drugs (1980) 0.79
Short or long hospitalization for psychiatric disorders? Two-year results [proceedings]. Psychopharmacol Bull (1977) 0.79
Toward an understanding of cortisol dysregulation in major depression: a review of studies of the dexamethasone suppression test and urinary free-cortisol. Psychiatr Med (1985) 0.79
Electrophysiologic abnormalities in patients with eating disorders. Compr Psychiatry (1984) 0.78
MRI deep white matter hyperintensity in a psychiatric population. Biol Psychiatry (1991) 0.78
Methods for large scale recording of clinical ratings. J Psychiatr Res (1968) 0.78
Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry (1999) 0.78
Psychiatric symptoms in Behçet's syndrome. Psychosomatics (1985) 0.78
Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry (1983) 0.77
Steroid modulation of human memory: biochemical correlates. Biol Psychiatry (1993) 0.77
Hormonal changes with cholesterol reduction: a double-blind pilot study. J Clin Pharm Ther (2004) 0.77
Cultural influences on diagnosis and perception of Tourette syndrome in Costa Rica. J Am Acad Child Adolesc Psychiatry (2001) 0.77
Evidence for physiological effects of hypercortisolemia in psychiatric patients. Psychiatry Res (1985) 0.77
Self-regulation of dose in methadone maintenance with contingent privileges. Addict Behav (1979) 0.77
Pineal-adrenal interactions: the effect of acute pharmacological blockade of nocturnal melatonin secretion. Psychiatry Res (1990) 0.77
Treatment costs and patient outcomes with use of risperidone in a public mental health setting. Psychiatr Serv (1999) 0.77
Lithium carbonate and L-tryptophan in the treatment of bipolar and schizoaffective disorders. Am J Psychiatry (1983) 0.77
Regulation of ACTH and cortisol in depression. Peptides (1984) 0.76
Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Psychiatry Res (1984) 0.76
Clozapine eligibility: the effect of stringent criteria on ethnic, gender and age subgroups of schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (1996) 0.76
Possible interaction of tramadol and antidepressants. Am J Psychiatry (2000) 0.76
Clozapine's cost effectiveness. Am J Psychiatry (1995) 0.75
Psychiatry-epitomes of progress: screening for endogenous depression: the dexamethasone suppression test. West J Med (1981) 0.75
Are stress hormones and serotonin related to aggression in primates? Arch Gen Psychiatry (1994) 0.75
Mind and brain. Science (1993) 0.75
Magnetic resonance spectroscopy and psychiatry. West J Med (1996) 0.75
Short versus long hospital treatment of schizophrenia. Calif Med (1972) 0.75
Genetics of mental illness. West J Med (1987) 0.75
The etiology of schizophrenia: a replication test of the social selection vs. the social causation hypotheses. Acta Psychiatr Scand (1987) 0.75
Therapist A--B score and treatment outcome with psychiatric in patients: a table of random numbers. Br J Med Psychol (1979) 0.75
Dexamethasone for depression. Am J Psychiatry (1996) 0.75
Renal lithium clearance as a rapid and accurate predictor of maintenance dose. Am J Psychiatry (1982) 0.75
Rate of interaction between nursing staff and psychiatric patients. Nurs Res (1969) 0.75
Cortisol and behaviorally conditioned histamine release. Ann N Y Acad Sci (1987) 0.75
A neuroanatomic perspective on state-dependent learning: the role of the striatum. Acta Neurol Scand Suppl (1986) 0.75